Biotronik, Inc.   Report issue

For profit Phase 4
Founded: Berlin Germany (1999)
Status: No NME R&D (1999)

Organization Overview

First Clinical Trial
2008
NCT00559988
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Biotronik SE & Co. KG